Tumor Microenvironment Based on Extracellular Matrix Hydrogels for On-Chip Drug Screening

Area of Science:

• Biotechnology
• Nanotechnology
• Cancer Research

Background:

• Traditional drug screening methods face limitations, especially for complex tumors like neuroblastoma.
• Three-dimensional (3D) culturing and nanotechnology offer advanced solutions for drug discovery.
• Simulating the tumor microenvironment is crucial for accurate therapeutic efficacy evaluation.

Purpose of the Study:

• To develop a high-throughput microfluidic chip for enhanced drug screening.
• To create a vascularized tumor microenvironment using 3D co-culture.
• To precisely control nanomedicine concentrations for evaluating therapeutic efficacy.

Main Methods:

• Integration of a concentration gradient generator (CGG) with a 3D co-culture system on a microfluidic chip.
• Co-culturing neuroblastoma (SY5Y cell line) and human brain microvascular endothelial cells (HBMVECs).
• Utilizing decellularized extracellular matrix (dECM) hydrogels to construct the tumor microenvironment.

Main Results:

• The developed platform successfully simulates a vascularized tumor microenvironment.
• Precise control over nanomedicine concentrations was achieved, crucial for efficacy studies.
• The high-throughput system significantly accelerated the drug discovery process.

Conclusions:

• The microfluidic chip enhances the simulation of the tumor microenvironment for drug screening.
• This automated platform revolutionizes drug discovery by enabling efficient screening in a biologically relevant setting.
• The technology holds significant potential for accelerating the development of new cancer therapies.